Clinical Trial Update: RZL-012 for Dercum's Disease Lipomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of RZL-012 for Dercum's Disease Lipomas has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dercum Disease
• Dercum Disease Lipomas

Drugs mentioned

• RZL-012

Snippet

Sponsor: Raziel Therapeutics Ltd. | Conditions: Dercum's Disease Lipomas | Phase 2 | Status: COMPLETED | Results posted: 2024-02-07